Evaluating the Efficacy of the Mediterranean Diet to the Low- Fermentable, Oligosaccharides, Disaccharides, Monosaccharides, and Polyols (FODMAP) Diet in Treating Irritable Bowel Syndrome(IBS) - Trial NCT05807919
Access comprehensive clinical trial information for NCT05807919 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Michigan and is currently Recruiting. The study focuses on Irritable Bowel Syndrome. Target enrollment is 20 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
University of Michigan
Timeline & Enrollment
N/A
Apr 10, 2023
Apr 01, 2024
Primary Outcome
Proportion of patients that are responders based on the abdominal pain intensity score for at least 2 of the 4 weeks
Summary
This study is being completed to determine if the Mediterranean (MD) and low FODMAP
 (fermentable, oligosaccharides, disaccharides, monosaccharides, and polyols) diets are
 comparable in the effectiveness to treat Irritable Bowel Syndrome (IBS).
 
 The study team hypothesizes that:
 
 - The low FODMAP and Mediterranean groups will achieve a similar improvement in abdominal
 pain
 
 - Both groups will achieve similar improvements in bloating, overall IBS symptom severity,
 and adequate relief
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05807919
Non-Device Trial